Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ros Quinlivan

Showing results (11-20 of 84) with videos related to

Pageof 9
Sort By:
Neuromuscular Disorders : NMD|November 2, 2023
Life-threatening bowel complications in adults with Duchenne muscular dystrophy: a case seriesLuca Nart, Mahalekshmi Desikan, Anton Emmanuel, et al.
Developmental Medicine and Child Neurology|February 12, 2011
Hereditary motor sensory neuropathy (type 1) presenting with transient and persistent central nervous system manifestations: a novel genetic mutationMichael Absoud, Louise Brueton, Rajat Gupta, et al.
JPGN Reports|May 19, 2023
Congenital Myotonic Dystrophy with Combined Heterozygous ATP8B1/ABCB4 Mutation Leading to Progressive Cholestasis and Liver FailureFang Kuan Chiou, Hina Rizvi, Ros Quinlivan, et al.
Neuromuscular Disorders : NMD|May 29, 2021
Clinical outcome of SARS-CoV-2 infection in 7 adults with Duchenne muscular dystrophy attending a specialist neuromuscular centreRos Quinlivan, Mahalekshmi Desikan, Francis Cruces, et al.
Neuromuscular Disorders : NMD|February 27, 2019
236th ENMC International Workshop Bone protective therapy in Duchenne muscular dystrophy: Determining the feasibility and standards of clinical trials Hoofddorp, The Netherlands, 1-3 June 2018Sze Choong Wong, Volker Straub, Leanne M Ward, et al.
Neuromuscular Disorders : NMD|January 9, 2024
Neurodiversity, treatment compliance and survival in adults with Duchenne muscular dystrophy: a single-centre retrospective cohort reviewLuca Nart, Mahalekshmi Desikan, Aleksandra Pietrusz, et al.
Neuromuscular Disorders : NMD|February 10, 2022
Erratum to ``Clinical practice guidelines for glycogen storage disease V & VII (McArdle disease and Tarui disease) from an international study group'' [Neuromuscular Disorders 31 (2021) 1296-1310]Alejandro Lucia, Andrea Martinuzzi, Gisela Nogales-Gadea, et al.
Bone|January 26, 2025
Pharmacological and non-pharmacological therapies for prevention and treatment of osteoporosis in Duchenne Muscular Dystrophy: A systematic reviewSarah McCarrison, Shima Abdelrahman, Ros Quinlivan, et al.
Neuromuscular Disorders : NMD|December 1, 2021
Clinical practice guidelines for glycogen storage disease V & VII (McArdle disease and Tarui disease) from an international study groupAlejandro Lucia, Andrea Martinuzzi, Gisela Nogales-Gadea, et al.
British Journal of Sports Medicine|July 4, 2012
The 'McArdle paradox': exercise is a good advice for the exercise intolerantAlejandro Lucia, Ros Quinlivan, Andrew Wakelin, et al.
Pageof 9

Showing results (11-20 of 84) with videos related to

Sort By:
Pageof 9
Neuromuscular Disorders : NMD|November 2, 2023
Life-threatening bowel complications in adults with Duchenne muscular dystrophy: a case seriesLuca Nart, Mahalekshmi Desikan, Anton Emmanuel, et al.
Developmental Medicine and Child Neurology|February 12, 2011
Hereditary motor sensory neuropathy (type 1) presenting with transient and persistent central nervous system manifestations: a novel genetic mutationMichael Absoud, Louise Brueton, Rajat Gupta, et al.
JPGN Reports|May 19, 2023
Congenital Myotonic Dystrophy with Combined Heterozygous ATP8B1/ABCB4 Mutation Leading to Progressive Cholestasis and Liver FailureFang Kuan Chiou, Hina Rizvi, Ros Quinlivan, et al.
Neuromuscular Disorders : NMD|May 29, 2021
Clinical outcome of SARS-CoV-2 infection in 7 adults with Duchenne muscular dystrophy attending a specialist neuromuscular centreRos Quinlivan, Mahalekshmi Desikan, Francis Cruces, et al.
Neuromuscular Disorders : NMD|February 27, 2019
236th ENMC International Workshop Bone protective therapy in Duchenne muscular dystrophy: Determining the feasibility and standards of clinical trials Hoofddorp, The Netherlands, 1-3 June 2018Sze Choong Wong, Volker Straub, Leanne M Ward, et al.
Neuromuscular Disorders : NMD|January 9, 2024
Neurodiversity, treatment compliance and survival in adults with Duchenne muscular dystrophy: a single-centre retrospective cohort reviewLuca Nart, Mahalekshmi Desikan, Aleksandra Pietrusz, et al.
Neuromuscular Disorders : NMD|February 10, 2022
Erratum to ``Clinical practice guidelines for glycogen storage disease V & VII (McArdle disease and Tarui disease) from an international study group'' [Neuromuscular Disorders 31 (2021) 1296-1310]Alejandro Lucia, Andrea Martinuzzi, Gisela Nogales-Gadea, et al.
Bone|January 26, 2025
Pharmacological and non-pharmacological therapies for prevention and treatment of osteoporosis in Duchenne Muscular Dystrophy: A systematic reviewSarah McCarrison, Shima Abdelrahman, Ros Quinlivan, et al.
Neuromuscular Disorders : NMD|December 1, 2021
Clinical practice guidelines for glycogen storage disease V & VII (McArdle disease and Tarui disease) from an international study groupAlejandro Lucia, Andrea Martinuzzi, Gisela Nogales-Gadea, et al.
British Journal of Sports Medicine|July 4, 2012
The 'McArdle paradox': exercise is a good advice for the exercise intolerantAlejandro Lucia, Ros Quinlivan, Andrew Wakelin, et al.
Pageof 9